Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Download All
Get up to date on key topics in the management of patients with HER2-positive breast cancer with downloadable slides and an on-demand webcast from a live webinar, expert commentaries and a podcast on HER2-positive breast cancer, and an updated Interactive Decision Support Tool for HER2-positive MBC.
Aditya Bardia, MD, MPH
Sara Hurvitz, MD, FACP
Kristi Kay Orbaugh, MSN, NP, AOCNP
Danielle Roman, PharmD, BCOP

ClinicalThought

In this commentary, 2 oncologists, an oncology nurse, and a pharmacist discuss how recent data on HER2-targeted treatment are changing the therapeutic paradigm in early and metastatic breast cancer.

Aditya Bardia, MD, MPH Sara Hurvitz, MD, FACP Kristi Kay Orbaugh, MSN, NP, AOCNP Danielle Roman, PharmD, BCOP Released: May 10, 2022
Provided by Clinical Care Options, LLC in partnership with Smart Patients.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Supported by educational grants from
AstraZeneca
Daiichi Sankyo, Inc.
Puma Biotechnology, Inc.
Seagen Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings